Citadel Advisors’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-132,322
| Closed | -$22.8K | – | 6980 |
|
|
2022
Q4 | $22.8K | Sell |
132,322
-9,458
| -7% | -$1.63K | ﹤0.01% | 5528 |
|
|
2022
Q3 | $62K | Sell |
141,780
-211,030
| -60% | -$92.3K | ﹤0.01% | 5256 |
|
|
2022
Q2 | $300K | Buy |
352,810
+64,281
| +22% | +$54.7K | ﹤0.01% | 4635 |
|
|
2022
Q1 | $1.59M | Buy |
288,529
+227,686
| +374% | +$1.25M | ﹤0.01% | 3262 |
|
|
2021
Q4 | $589K | Buy |
60,843
+41,794
| +219% | +$405K | ﹤0.01% | 4422 |
|
|
2021
Q3 | $341K | Buy |
+19,049
| New | +$341K | ﹤0.01% | 4911 |
|
|
2021
Q1 | – | Sell |
-70,955
| Closed | -$539K | – | 6987 |
|
|
2020
Q4 | $539K | Sell |
70,955
-12,334
| -15% | -$93.7K | ﹤0.01% | 3791 |
|
|
2020
Q3 | $417K | Buy |
83,289
+49,587
| +147% | +$248K | ﹤0.01% | 3633 |
|
|
2020
Q2 | $202K | Sell |
33,702
-106,701
| -76% | -$640K | ﹤0.01% | 4066 |
|
|
2020
Q1 | $625K | Sell |
140,403
-52,462
| -27% | -$234K | ﹤0.01% | 3238 |
|
|
2019
Q4 | $1.83M | Sell |
192,865
-73,596
| -28% | -$699K | ﹤0.01% | 2441 |
|
|
2019
Q3 | $2.09M | Buy |
266,461
+51,498
| +24% | +$404K | ﹤0.01% | 2347 |
|
|
2019
Q2 | $3.38M | Buy |
+214,963
| New | +$3.38M | ﹤0.01% | 1974 |
|